Nanocell attack: new combo therapy takes on tough pancreatic cancer
Disease control
Recruiting now
This study tests whether adding specially designed nanocells (tiny particles that deliver a potent drug directly to cancer cells) to standard chemotherapy can help people with metastatic pancreatic cancer live longer. About 144 adults whose cancer has worsened despite prior treat…
Phase: PHASE1, PHASE2 • Sponsor: Engeneic Pty Limited • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC